As the number of laparoscopic procedures being performed at hospitals and surgery centers outgrows the number of open surgeries, facilities are investing millions of dollars into equipment to improve these procedures, like high-definition optics. But high definition video systems aren’t serving their purpose if the surgeon’s view is obstructed by fog and debris during surgery. […]
Canaan Partners has announced a new $600 million fund of which one-third will be dedicated to medical device, biopharmaceuticals and diagnostics investing. About a quarter of the investments will likely be outside the United States, primarily Israel and India. Most of the investments will be in early and seed-stage companies. Its most recent life science […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Antiviral therapies pharmaceutical company Chimerix has raised $45 million that it will apply toward further clinical development of two compounds, one of which could be used as a defense against biological attacks. The Durham, North Carolina-based company is developing another compound for infections associated with HIV.
CoAxia thinks its NeuroFlo technology could be part of basic care for 500,000 ischemic stroke patients, breaking into a market worth more than $1 billion. Instead of attacking the brain clot, its catheter diverts blood flow from the lower parts of the body and pushes it into the brain to increase blood flow.